FDA approves new version of diabetes drug Mounjaro for weight loss

Do you agree with the decision to send weapons, soldier and ships to the Middle East as a deterrent in the Israel-Hamas war?

Zepbound is the latest diabetes drug approved for weight loss, joining Novo Nordisk’s Wegovy, a high-dose version of its diabetes treatment Ozempic. “This would be the most highly efficacious drug ever approved for the treatment of obesity,” said Dr. Fatima Cody Stanford, an obesity medicine expert at Massachusetts General Hospital in Boston.

While experts lauded approval of Zepbound, they worried that it wouldn’t necessarily mean greater access to the drug, which has been prescribed “off-label” to help people pare pounds.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA approves new version of diabetes drug Mounjaro for weight lossFederal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug
Source: KIRO7Seattle - 🏆 271. / 63 Read more »

FDA approves new version of diabetes drug Mounjaro for weight lossFederal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug. The Food and Drug Administration approved Zepbound on Wednesday. The drug has been shown to help dieters lose about a quarter of their body weight, or 60 pounds.
Source: AP - 🏆 728. / 51 Read more »

Eli Lilly’s Mounjaro Approved for Weight Loss in the U.S.The drug, which will be sold as Zepbound as an anti-obesity treatment, had previously been cleared by the FDA for the treatment of Type 2 diabetes
Source: WSJ - 🏆 98. / 63 Read more »